Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease

Journal of the American College of Cardiology

Volumn 31, Issue 2, 1998, Pages 352-358

  Furman, Mark I ^a   Benoit, Stephen E ^a   Barnard, Marc R ^a   Valeri, C Robert ^b   Borbone, Marie L ^a   Becker, Richard C ^a   Hechtman, Herbert B ^c   Michelson, Alan D ^a  

^a Center for Platelet Function Studies   (United States)

^b BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; ATHEROSCLEROSIS; BLOOD FLOWMETRY; CLINICAL ARTICLE; CORONARY ARTERY DILATATION; CORONARY ARTERY DISEASE; FEMALE; FLOW CYTOMETRY; HUMAN; LEUKOCYTE ACTIVATION; MALE; PRIORITY JOURNAL; THROMBOCYTE ACTIVATION; THROMBOCYTE AGGREGATION; THROMBOSIS; VENOUS BLOOD;

ADENOSINE DIPHOSPHATE; ADULT; ANGINA PECTORIS; CELL ADHESION; CELL ADHESION MOLECULES; CELL COUNT; CELL DEGRANULATION; CELL MOVEMENT; CORONARY ARTERIOSCLEROSIS; CORONARY DISEASE; CORONARY VESSELS; EPINEPHRINE; FEMALE; FLOW CYTOMETRY; HUMANS; LEUKOCYTES; MALE; MIDDLE AGED; MONOCYTES; P-SELECTIN; PEPTIDE FRAGMENTS; PLATELET ACTIVATION; PLATELET AGGREGATION; RECEPTORS, THROMBIN; THROMBOSIS;

EID: 0031955060     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(97)00510-X     Document Type: Article

References (56)

1. Munro JM, Cotran RS. The pathogenesis of atherosclerosis atherogenesis and inflammation . Lab Invest. 58:1988;249-261.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes. N Engl J Med. 326:1992;242-250.
3. Ross R. The pathogenesis of atherosclerosis a perspective for the 1990s . Nature. 362:1993;801-809.
4. Marcus AJ, Safier LB. Thromboregulation multicellular modulation of platelet reactivity in hemostasis and thrombosis . FASEB J. 7:1993;516-522.
5. Marcus AJ. Thrombosis and inflammation as multicellular processes significance of cell-cell interactions . Semin Hematol. 31:1994;261-269.
6. Rinder HM, Bonan JL, Rinder CS, Ault KA, Smith BR. Dynamics of leukocyte-platelet adhesion in whole blood. Blood. 78:1991;1730-1737.
7. Rinder HM, Bonan JL, Ridner CS, Ault KA, Smith BR. Activated and unactivated platelet adhesion to monocytes and neutrophils. Blood. 78:1991;1760-1769.
8. Rinder CS, Bonan JL, Rinder HM, Matthew J, Hines R, Smith BR. Cardiopulmonary bypass induces leukocyte-platelet adhesion. Blood. 79:1992;1201-1205.
9. Mickelson JK, Lakkis NM, Villarreallevy G, Hughes BJ, Smith CW. Leukocyte activation with platelet adhesion after coronary angioplasty a mechanism for recurrent disease? J Am Coll Cardiol. 28:1996;345-353.
10. Ott I, Neumann FJ, Gawaz M, Schmitt M, Schomig A. Increased neutrophil-platelet adhesion in patients with unstable angina. Circulation. 94:1996;1239-1246.
11. Fitzgerald DJ, Roy L, Catella F, Fitzgerald GA. Platelet activation in unstable coronary disease. N Engl J Med. 315:1986;983-989.
12. Trip MD, Cats VM, Van Cappelle FJL, Vreeken J. Platelet hyperactivity and prognosis in survivors of myocardial infarction. N Engl J Med. 322:1990;1549-1554.
13. Roger M, Hogasen K, Mollnes TE, Hovig T. The membrane glycoprotein IIb/IIIa complex mediates deposition of thrombin-stimulated blood platelets on polystyrene plastic under static conditions. Platelets. 5:1994;96-104.
14. Ernst E, Hammerschmidt DE, Bagge U, Matrai A, Dormandy JA. Leukocytes and the risk of ischemic diseases. JAMA. 257:1987;2318-2324.
15. Furman MI, Becker RC, Yarzebski J, Savegeau J, Gore JM, Goldberg RJ. Effect of elevated leukocyte count on in-hospital mortality following acute myocardial infarction. Am J Cardiol. 78:1996;945-948.
16. Entman ML, Rossen RD, Dreyer WJ, Anderson DC, Taylor AA, Smith CW. Inflammation in the course of myocardial ischemia. FASEB J. 5:1991;2529-2537.
17. Alexander RW. Inflammation and coronary artery disease. N Engl J Med. 331:1994;468-469.
18. Treasure CB, Alexander RW. Relevance of vascular biology to the ischemic syndromes of coronary atherosclerosis. Cardiovasc Drugs Ther. 9:1995;13-19.
19. Stenberg PE, McEver RP, Shuman MA, Jacques YV, Bainton DF. A platelet alpha-granule membrane protein (GMP-140) is expressed on the plasma membrane after activation. J Cell Biol. 101:1985;880-887.
20. Berman CL, Yeo EL, Wencel-Drake JD, Furie BC, Ginsberg MH, Furie B. A platelet alpha granule membrane protein that is associated with the plasma membrane after activation. J Clin Invest. 78:1986;130-136.
21. Larsen E, Celi A, Gilbert GE, et al. PADGEM protein a receptor that mediates the interaction of activated platelets with neutrophils and monocytes . Cell. 59:1989;305-312.
22. Hamburger SA, McEver RP. GMP-140 mediates adhesion of stimulated platelets to neutrophils. Blood. 75:1990;550-554.
23. Wester J, Sixma JJ, Geuze JJ, Heijnen HFG. Morphology of the hemostatic plug in human skin wounds transformation of the plug . Lab Invest. 41:1979;182-192.
24. Lehr HA, Ologsson AM, Carew TE, et al. P-selectin mediates the interaction of circulating leukocytes with platelets and microvascular endothelium in response to oxidized lipoprotein in vivo. Lab Invest. 71:1994;380-386.
25. Lehr HA, Frei B, Arfors KE. Vitamin C prevents cigarette smoke-induced leukcotye aggregation and adhesion to endothelium in vivo. Proc Natl Acad Sci USA. 91:1994;7688-7692.
26. Michelson AD. Flow cytometry a clinical test of platelet function . Blood. 87:1996;4925-4936.
27. Michelson AD, Ellis PA, Barnard MR, Matic GB, Viles AF, Kestin AS. Downregulation of the platelet surface glycoprotein Ib-IX complex in whole blood stimulated by thrombin, ADP or an in vivo wound. Blood. 77:1991;770-779.
28. Gatter KC, Cordell JL, Turley H, et al. The immunohistological detection of platelets, megakaryocytes and thrombi in routinely processed specimens. Histopathology. 13:1988;257-267.
29. Coller BS, Peerschke EI, Scudder LE, Sullivan CA. A murine monoclonal antibody that completely blocks the binding of fibrinogen to platelets produces a thrombasthenic-like state in normal platelets and binds to glycoproteins IIb and/or IIIa. J Clin Invest. 72:1983;325-338.
30. Keizer G, Borst J, Figdor C, et al. Biochemical and functional characteristics of the human membrane antigen family LFA-1, MO-1. Eur J Immunol. 15:1985;1142-1149.
31. Michelson AD, Shattil SJ. The use of flow cytometry to study platelet activation. Watson SP, Authi K. Platelet Function and Signal Transduction A Practical Approach . 1996;111-129 Oxford University Press, Oxford (UK).
32. Hsu-Lin S, Berman CL, Furie BC, August D, Furie B. A platelet membrane protein expressed during platelet activation and secretion studies using a monoclonal antibody specific for thrombin-activated platelets . J Biol Chem. 259:1984;9121-9126.
33. Sobel M, Salzman EW, Davies GC, et al. Circulating platelet products in cardiovascular disease. Circulation. 63:1981;300-306.
34. Grande P, Grauhoult AM, Madsen JK. Platelet behavior and prognosis in progressive angina and intermediate coronary syndrome. Circulation. 81:(Suppl I):1990;I-16-I-19.
35. Hamm CW, Lorenz RL, Bleifield W, Kupper W, Wober K, Weber PC. Biochemical evidence of platelet activation in patients with unstable angina. J Am Coll Cardiol. 10:1987;998-1004.
36. Kaplan KL. Laboratory markers for platelet activation. Colman RW, Hirsh J, Marder VJ, Salzman EW. Hemostasis and Thrombosis Basic Principles and Clinical Practice . 3rd ed. 1994;1180-1196 JB Lippincott, Philadelphia.
37. Scharf RE, Tomer A, Marzec UM, Teirstein PS, Ruggeri ZM, Harker LA. Activation of platelets in blood perfusing angioplasty-damaged coronary arteries flow cytometric detection . Arterioscler Thromb Vasc Biol. 12:1992;1475-1487.
38. Tschoepe D, Schultheib HP, Kolarov P, et al. Platelet membrane activation markers are predictive for increased risk of acute ischemic events after PTCA. Circulation. 88:1993;37-42.
39. Itoh T, Nakai K, Ono M, Hiramori K. Can the risk for cardiac events in acute coronary syndrome be indicated by platelet membrane activation marker P-selectin? Coron Artery Dis. 6:1995;645-650.
40. Cahill MR, Macey MG, Dawson JR, Newland AC. Platelet surface activation antigen expression at baseline and during elective angioplasty in patients with mild to moderate coronary artery disease. Blood Coagul Fibrinolysis. 7:1996;165-168.
41. Becker RC, Tracy RP, Bovill EG, Mann KG, Ault K. The clinical use of flow cytometry for assessing platelet activation in acute coronary syndromes. Coron Artery Dis. 5:1994;339-345.
42. Freedman JE, Hankin B, Alpert C, Loscalzo J, Keaney JF, Vita JA. Impaired platelet production of nitric oxide in patients with coronary artery disease [abstract]. Circulation. 94:(Suppl I):1996;I-402.
43. Michelson AD, Barnard MR, Hechtman HB, et al. In vivo tracking of platelets circulating degranulated platelets rapidly lose surface P-selectin but continue to circulate and function . Proc Natl Acad Sci USA. 93:1996;11877-11882.
44. Davi G, Gresele P, Violi F, et al. Diabetes mellitus, hypercholesterolemia, and hypertension but not vascular disease per se are associated with persistent platelet activation in vivo. Circulation. 96:1997;69-75.
45. Altieri DC, Edginton TS. A monoclonal antibody reacting with distinct adhesion molecules defines a transition in the functional state of the receptor CD11b/CD18 (Mac-1). J Immunol. 141:1988;2656-2660.
46. Simon DI, Xu H, Ortlepp S, Rogers C, Rao NK. 7E3 monoclonal antibody directed against the platelet glycoprotein IIb/IIIa cross-reacts with leukocyte integrin Mac-1 and blocks adhesion to fibrinogen and ICAM-1. Arterioscler Thromb Vasc Biol. 17:1997;528-535.
47. Moore KL, Stults NL, Diaz S, et al. Identification of a specific glycoprotein ligand for P-selectin (CD62) on myeloid cells. J Cell Biol. 118:1992;445-456.
48. Sako D, Chang X-J, Barone KM, et al. Expression cloning of a functional glycoprotein ligand for P-selectin. Cell. 75:1993;1179-1186.
49. Moore KL, Patel KD, Bruehl RE, et al. P-selectin glycoprotein ligand-1 mediates rolling of human neutrophils on P-selectin. J Cell Biol. 128:1995;661-671.
50. Gawaz MP, Mujais SK, Schmidt B, Gurland HJ. Platelet-leukocyte aggregation during hemodialysis. Kidney Int. 46:1994;489-495.
51. Mendelsohn ME, Loscalzo J. Role of platelets in cholesterol ester formation by U937 cells. J Clin Invest. 81:1988;62-69.
52. Celi A, Pellegrini G, Lorenzet R, et al. P-selectin induces the expression of tissue factor on monocytes. Proc Natl Acad Sci USA. 91:1994;8767-8771.
53. Palabrica T, Lobb R, Furie RC, August D, Furie B. Leukocyte accumulation promoting fibrin deposition is mediated in vivo by P-selectin on adherent platelets. Nature. 359:1992;848-851.
54. Weyrich AS, Elstad MR, McEver RP, et al. Activated platelets signal chemokine synthesis by human monocytes. J Clin Invest. 97:1996;1525-1534.
55. Rinder CS, Student LA, Bonan JL, Rinder HM, Smith BR. Aspirin does not inhibit adenosine diphospate-induced platelet alpha granule release. Blood. 82:1993;505-512.
56. Chronos NAF, Wilson DJ, Janes SL, Hutton RA, Buller NP, Goodall AH. Aspirin does not affect the flow cytometric detection of fibrinogen binding to, or release of alpha-granules or lysosomes from human platelets. Clin Sci. 87:1994;575-580.